ArticleCureus2026
Immune-Mediated SARS-CoV-2-Induced Orchitis Leading to Complete Testicular Failure: A Report of a Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune orchitis is a rare cause of male infertility characterized by immune-mediated impairment of spermatogenesis. SARS-CoV-2 infection has been implicated in testicular inflammation and immune dysregulation, but reports of virus-associated autoimmune orchitis remain exceedingly uncommon. We describe a 40-year-old man with rapidly progressive infertility leading to azoospermia and testicular failure, occurring in the context of a balanced chromosomal translocation that may have conferred genetic susceptibility. Histological findings were consistent with autoimmune orchitis, and serological evidence indicated prior asymptomatic exposure to SARS-CoV-2 in the absence of recent vaccination, suggesting a potential immunological trigger. This case supports the hypothesis of a "second-hit" mechanism whereby virus-induced immune activation may accelerate testicular damage in genetically vulnerable individuals. To our knowledge, only a single-digit number of cases of SARS-CoV-2-associated autoimmune orchitis have been reported. Early fertility preservation, genetic and immunological evaluation, and long-term endocrine follow-up should be considered in men presenting with unexplained, rapidly progressive infertility. Further studies are needed to clarify the relationship between SARS-CoV-2, testicular autoimmunity, and male reproductive health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.